Education
About Us
Working with TipRanks
Follow Us
China Pharma Holdings (CPHI)
:CPHI
RESEARCH TOOLSreports
CPHI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.19 - $3.36
Previous CloseN/A
Volume1.29M
Average Volume (3M)56.15K
Market Cap
$5.26M
Enterprise Value$31.96M
Total Cash (Recent Filing)$412.69B
Total Debt (Recent Filing)$1.41T
Price to Earnings (P/E)―
Beta0.51
Next Earnings
May 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding3,262,002
10 Day Avg. Volume68,365
30 Day Avg. Volume56,149
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)5.88
Price to Sales (P/S)0.00
P/FCF Ratio-31.09
Enterprise Value/Market Cap6.07
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China Pharma Holdings News
PremiumCompany Announcements
China Pharma Holdings Announces Reverse Stock Split
PremiumCompany Announcements
China Pharma Holdings Announces Reverse Stock Split
PremiumCompany Announcements
China Pharma Holdings Issues 15M Unregistered Shares
PremiumCompany Announcements
China Pharma Holdings Acquires Psoriasis Patent and Profit DealOptions Prices
Currently, No data available
---
Ownership Overview
27.30%
Insiders
<0.01% Other Institutional Investors
72.70% Public Companies and
Individual Investors
CPHI FAQ
What was China Pharma Holdings’s price range in the past 12 months?
China Pharma Holdings lowest stock price was $1.19 and its highest was $3.36 in the past 12 months.
What is China Pharma Holdings’s market cap?
China Pharma Holdings’s market cap is $5.26M.
When is China Pharma Holdings’s upcoming earnings report date?
China Pharma Holdings’s upcoming earnings report date is May 15, 2025 which is 28 days ago.
How were China Pharma Holdings’s earnings last quarter?
China Pharma Holdings released its earnings results on May 16, 2024. The company reported -$0.073 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.073.
Is China Pharma Holdings overvalued?
According to Wall Street analysts China Pharma Holdings’s price is currently Overvalued.
Does China Pharma Holdings pay dividends?
China Pharma Holdings does not currently pay dividends.
What is China Pharma Holdings’s EPS estimate?
China Pharma Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Pharma Holdings have?
China Pharma Holdings has 3,262,002 shares outstanding.
What happened to China Pharma Holdings’s price movement after its last earnings report?
China Pharma Holdings reported an EPS of -$0.073 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.856%.
Which hedge fund is a major shareholder of China Pharma Holdings?
Currently, no hedge funds are holding shares in CPHI
China Pharma Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.47%
12-Months-Change
Fundamentals
Return on Equity
-59.14%
Trailing 12-Months
Asset Growth
-11.08%
Trailing 12-Months
Company Description
China Pharma Holdings
China Pharma Holdings, Inc. (CPHI) is a pharmaceutical company engaged in the development, manufacture, and marketing of a wide variety of pharmaceutical products. The company's primary focus is on the therapeutic areas of cardiovascular diseases, central nervous system disorders, infectious diseases, and other critical medical needs. With a strong emphasis on quality and innovation, China Pharma Holdings aims to meet the growing demand for effective and affordable healthcare solutions in China and other emerging markets.